1h Free Analyst Time
The tumor ablation market is forecasted to grow by USD 1432.8 million during 2023-2028, accelerating at a CAGR of 14.62% during the forecast period. The report on the tumor ablation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing preference for minimally invasive procedures, continued emphasis on personalized medicine and targeted therapies, and rising focus on cancer treatment in outpatient settings.
The tumor ablation market is segmented as below:
By Type
- Radiofrequency ablation
- Microwave ablation
- Cryoablation
- Others
By Application
- Liver cancer
- Lung cancer
- Kidney cancer
- Breast and others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the tumor ablation market covers the following areas:
- Tumor ablation market sizing
- Tumor ablation market forecast
- Tumor ablation market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global tumor ablation market: Alpinion Medical Systems Co. Ltd., AngioDynamics Inc., Apyx Medical Corp., Bioventus LLC, Boston Scientific Corp., BVM Medical Ltd., EDAP TMS, ForTec Medical, IceCure Medical Ltd., Johnson and Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., Mermaid Medical Group, Monteris Medical Corp., Olympus Europa SE and Co. KG, Profound Medical Corp., Smith and Nephew plc, Stryker Corp., TechsoMed Medical Technologies Ltd., Terumo Corp., and Varian Medical Systems Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing adoption of image-guided tumor ablation."
According to the report, one of the major drivers for this market is the growing preference for minimally invasive procedures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alpinion Medical Systems Co. Ltd.
- AngioDynamics Inc.
- Apyx Medical Corp.
- Bioventus LLC
- Boston Scientific Corp.
- BVM Medical Ltd.
- EDAP TMS
- ForTec Medical
- IceCure Medical Ltd.
- Johnson and Johnson Services Inc.
- Medtronic Plc
- Merit Medical Systems Inc.
- Mermaid Medical Group
- Monteris Medical Corp.
- Olympus Europa SE and Co. KG
- Profound Medical Corp.
- Smith and Nephew plc
- Stryker Corp.
- TechsoMed Medical Technologies Ltd.
- Terumo Corp.
- Varian Medical Systems Inc.
